![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 46, 44485-44496, November 15, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Divisions of The expression of the matrix cytokine osteopontin
(OPN) is up-regulated in aortic vascular smooth muscle cells (VSMCs) by diabetes. OPN expression in cultured VSMCs is reciprocally
regulated by glucose and 2-deoxyglucose (2-DG; inhibitor of cellular
glucose metabolism). Systematic analyses of OPN
promoter-luciferase reporter constructs identify a CCTCATGAC
motif at nucleotides
Osteopontin Transcription in Aortic Vascular Smooth Muscle Cells
Is Controlled by Glucose-regulated Upstream Stimulatory Factor and
Activator Protein-1 Activities*
§,
,
,
,
§¶
Bone and Mineral Diseases and
§ Endocrinology, Diabetes, and Metabolism, Department of
Internal Medicine, Washington University School of Medicine, St. Louis,
Missouri 63110
80 to
72 relative to the initiation site that
supports OPN transcription in VSMCs. The region
83 to
45 encompassing this motif confers basal and glucose- and
2-DG-dependent transcription on an unresponsive promoter.
Competition and gel mobility supershift assays identify upstream
stimulatory factor (USF; USF1:USF2) and activator protein-1 (AP1;
c-Fos:c-Jun) in complexes binding the composite CCTCATGAC element.
Glucose up-regulates both AP1 and USF binding activities 2-fold in A7r5
cells and selectively up-regulates USF1 protein levels. By contrast,
USF (but not AP1) binding activity is suppressed by 2-DG and restored
by glucose treatment. Expression of either USF or AP1 activates the
proximal OPN promoter in A7r5 VSMCs in part via the
CCTCATGAC element. Moreover, glucose stimulates the transactivation
functions of c-Fos and USF1, but not c-Jun, in one-hybrid assays.
Mannitol does not regulate binding, transactivation functions, USF1
protein accumulation, or OPN transcription. Thus, OPN gene transcription is regulated by USF and AP1 in aortic VSMCs, entrained to changes in cellular glucose metabolism.
*
This work was supported by Grants HL69229 and DK52446 (to
D. A. T.) from the National Institutes of Health and by the
Barnes-Jewish Hospital Research Foundation.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
R. Eferl, P. Hasselblatt, M. Rath, H. Popper, R. Zenz, V. Komnenovic, M.-H. Idarraga, L. Kenner, and E. F. Wagner Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1 PNAS, July 29, 2008; 105(30): 10525 - 10530. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Whalen, G. F. Weber, T. L. Benjamin, and B. S. Schaffhausen Polyomavirus Middle T Antigen Induces the Transcription of Osteopontin, a Gene Important for the Migration of Transformed Cells J. Virol., May 15, 2008; 82(10): 4946 - 4954. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kristiansson, E. Ilveskoski, T. Lehtimaki, L. Peltonen, M. Perola, and P. J. Karhunen Association Analysis of Allelic Variants of USF1 in Coronary Atherosclerosis Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 983 - 989. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A Zirngibl, J. S M Chan, and J. E Aubin Estrogen receptor-related receptor {alpha} (ERR{alpha}) regulates osteopontin expression through a non-canonical ERR{alpha} response element in a cell context-dependent manner J. Mol. Endocrinol., February 1, 2008; 40(2): 61 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Towler Vascular Calcification: A Perspective On An Imminent Disease Epidemic IBMS BoneKEy, February 1, 2008; 5(2): 41 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. SHAO, Z. A. ALY, C.-F. LAI, S.-L. CHENG, J. CAI, E. HUANG, A. BEHRMANN, and D. A. TOWLER Vascular Bmp Msx2 Wnt Signaling and Oxidative Stress in Arterial Calcification Ann. N.Y. Acad. Sci., November 1, 2007; 1117(1): 40 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Miller, W. C. Watson, K. A. Kerr, C. A. Labarrere, N. X. Chen, M. A. Deeg, and J. L. Unthank Development of progressive aortic vasculopathy in a rat model of aging Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2634 - H2643. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liu, L. Shi, and S. Wang Overexpression of upstream stimulatory factor 2 accelerates diabetic kidney injury Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1727 - F1735. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jalvy, M.-A. Renault, L. L. S. Leen, I. Belloc, J. Bonnet, A.-P. Gadeau, and C. Desgranges Autocrine expression of osteopontin contributes to PDGF-mediated arterial smooth muscle cell migration Cardiovasc Res, September 1, 2007; 75(4): 738 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Rodrigues, J. A. Teixeira, F. L. Schmitt, M. Paulsson, and H. Lindmark-Mansson The Role of Osteopontin in Tumor Progression and Metastasis in Breast Cancer Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1087 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakamachi, T. Nomiyama, F. Gizard, E. B. Heywood, K. L. Jones, Y. Zhao, L. Fuentes, K. Takebayashi, Y. Aso, B. Staels, et al. PPAR{alpha} Agonists Suppress Osteopontin Expression in Macrophages and Decrease Plasma Levels in Patients With Type 2 Diabetes Diabetes, June 1, 2007; 56(6): 1662 - 1670. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jalvy, M.-A. Renault, L. Lam Shang Leen, I. Belloc, A. Reynaud, A.-P. Gadeau, and C. Desgranges CREB Mediates UTP-Directed Arterial Smooth Muscle Cell Migration and Expression of the Chemotactic Protein Osteopontin via Its Interaction with Activator Protein-1 Sites Circ. Res., May 11, 2007; 100(9): 1292 - 1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, J. S. Bailey, D. Coss, B. Lin, R. Tsutsumi, M. A. Lawson, P. L. Mellon, and N. J. G. Webster Activin Modulates the Transcriptional Response of L{beta}T2 Cells to Gonadotropin-Releasing Hormone and Alters Cellular Proliferation Mol. Endocrinol., November 1, 2006; 20(11): 2909 - 2930. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-F. Lai, V. Seshadri, K. Huang, J.-S. Shao, J. Cai, R. Vattikuti, A. Schumacher, A. P. Loewy, D. T. Denhardt, S. R. Rittling, et al. An Osteopontin-NADPH Oxidase Signaling Cascade Promotes Pro-Matrix Metalloproteinase 9 Activation in Aortic Mesenchymal Cells Circ. Res., June 23, 2006; 98(12): 1479 - 1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Vietor, R. Kurzbauer, G. Brosch, and L. A. Huber TIS7 Regulation of the {beta}-Catenin/Tcf-4 Target Gene Osteopontin (OPN) Is Histone Deacetylase-dependent J. Biol. Chem., December 2, 2005; 280(48): 39795 - 39801. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhu, M. Casado, S. Vaulont, and K. Sharma Role of Upstream Stimulatory Factors in Regulation of Renal Transforming Growth Factor-{beta}1 Diabetes, July 1, 2005; 54(7): 1976 - 1984. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sakamoto, M. Chen, T. Nakamura, T. Xie, G. Karsenty, and L. S. Weinstein Deficiency of the G-protein {alpha}-Subunit Gs{alpha} in Osteoblasts Leads to Differential Effects on Trabecular and Cortical Bone J. Biol. Chem., June 3, 2005; 280(22): 21369 - 21375. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sellak, C. Choi, N. Browner, and T. M. Lincoln Upstream Stimulatory Factors (USF-1/USF-2) Regulate Human cGMP-dependent Protein Kinase I Gene Expression in Vascular Smooth Muscle Cells J. Biol. Chem., May 6, 2005; 280(18): 18425 - 18433. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ogawa, J. F. Stone, Y. Takata, F. Blaschke, V. H. Chu, D. A. Towler, R. E. Law, W. A. Hsueh, and D. Bruemmer Liver X Receptor Agonists Inhibit Cytokine-Induced Osteopontin Expression in Macrophages Through Interference With Activator Protein-1 Signaling Pathways Circ. Res., April 15, 2005; 96(7): e59 - e67. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-A. Renault, S. Jalvy, M. Potier, I. Belloc, E. Genot, L. V. Dekker, C. Desgranges, and A.-P. Gadeau UTP Induces Osteopontin Expression through a Coordinate Action of NF{kappa}B, Activator Protein-1, and Upstream Stimulatory Factor in Arterial Smooth Muscle Cells J. Biol. Chem., January 28, 2005; 280(4): 2708 - 2713. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wang, J. Skorczewski, X. Feng, L. Mei, and J. E. Murphy-Ullrich Glucose Up-regulates Thrombospondin 1 Gene Transcription and Transforming Growth Factor-{beta} Activity through Antagonism of cGMP-dependent Protein Kinase Repression via Upstream Stimulatory Factor 2 J. Biol. Chem., August 13, 2004; 279(33): 34311 - 34322. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Abedin, Y. Tintut, and L. L. Demer Vascular Calcification: Mechanisms and Clinical Ramifications Arterioscler. Thromb. Vasc. Biol., July 1, 2004; 24(7): 1161 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. El-Tanani, A. Platt-Higgins, P. S. Rudland, and F. C. Campbell Ets Gene PEA3 Cooperates with {beta}-Catenin-Lef-1 and c-Jun in Regulation of Osteopontin Transcription J. Biol. Chem., May 14, 2004; 279(20): 20794 - 20806. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vattikuti and D. A. Towler Osteogenic regulation of vascular calcification: an early perspective Am J Physiol Endocrinol Metab, May 1, 2004; 286(5): E686 - E696. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Weigert, K. Brodbeck, M. Sawadogo, H. U. Haring, and E. D. Schleicher Upstream Stimulatory Factor (USF) Proteins Induce Human TGF-{beta}1 Gene Activation via the Glucose-response Element-1013/-1002 in Mesangial Cells: UP-REGULATION OF USF ACTIVITY BY THE HEXOSAMINE BIOSYNTHETIC PATHWAY J. Biol. Chem., April 16, 2004; 279(16): 15908 - 15915. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Shao, S.-L. Cheng, N. Charlton-Kachigian, A. P. Loewy, and D. A. Towler Teriparatide (Human Parathyroid Hormone (1-34)) Inhibits Osteogenic Vascular Calcification in Diabetic Low Density Lipoprotein Receptor-deficient Mice J. Biol. Chem., December 12, 2003; 278(50): 50195 - 50202. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-L. Cheng, J.-S. Shao, N. Charlton-Kachigian, A. P. Loewy, and D. A. Towler Msx2 Promotes Osteogenesis and Suppresses Adipogenic Differentiation of Multipotent Mesenchymal Progenitors J. Biol. Chem., November 14, 2003; 278(46): 45969 - 45977. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Beck Jr. and N. Knecht Osteopontin Regulation by Inorganic Phosphate Is ERK1/2-, Protein Kinase C-, and Proteasome-dependent J. Biol. Chem., October 24, 2003; 278(43): 41921 - 41929. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-A. Renault, S. Jalvy, I. Belloc, S. Pasquet, S. Sena, M. Olive, C. Desgranges, and A.-P. Gadeau AP-1 Is Involved in UTP-Induced Osteopontin Expression in Arterial Smooth Muscle Cells Circ. Res., October 3, 2003; 93(7): 674 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Kumar and G. K. Owens Combinatorial Control of Smooth Muscle-Specific Gene Expression Arterioscler. Thromb. Vasc. Biol., May 1, 2003; 23(5): 737 - 747. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |